Charlotte's Web
Sativa-dominant Hybrid
THC: 0.3-1%
CBD: 15-20%
Flowering: 8-9 weeks
A renowned high-CBD strain developed for its therapeutic properties, often used to treat seizures and inflammation.
$29.99
In Stock
1
About Charlotte's Web
Charlotte's Web is a renowned cannabis strain celebrated for its high CBD content and therapeutic properties. Developed by the Stanley Brothers in Colorado, this sativa-dominant hybrid was specifically bred to help manage seizures and other medical conditions. The strain gained international attention after it was used to treat Charlotte Figi, a young girl with Dravet syndrome, significantly reducing her seizure frequency. Charlotte's Web is a cross of industrial hemp strains, resulting in a plant with minimal THC levels, typically below 0.3%, making it non-psychoactive and legal in many regions.
In terms of appearance, Charlotte's Web plants are characterized by their tall, lanky structure typical of sativa-dominant strains. The buds are dense and olive green, often adorned with a generous coating of trichomes that give them a frosty appearance. The aroma of Charlotte's Web is subtle yet pleasant, with earthy undertones complemented by hints of pine and citrus. This mild scent profile makes it an appealing choice for those who prefer a less pungent cannabis experience.
The effects of Charlotte's Web are primarily therapeutic, offering a sense of calm and relaxation without the psychoactive high associated with THC-rich strains. Its high CBD content makes it particularly effective in managing seizures, inflammation, and chronic pain. Additionally, users have reported benefits in alleviating anxiety, stress, and insomnia. Charlotte's Web is often chosen by those seeking relief from medical conditions without the intoxicating effects, making it a popular choice for patients and caregivers alike.
Origin
Information not available
Genetics
Information not available
Ideal For
Information not available